Cargando…

Trends in Use of Single- vs Dual-Chamber Implantable Cardioverter-Defibrillators Among Patients Without a Pacing Indication, 2010-2018

IMPORTANCE: Use of dual-chamber implantable cardioverter-defibrillator (ICD) systems among patients without a pacing indication is an example of low-value care given higher procedural risks, higher costs, and little evidence for benefit from an atrial lead. However, variation in the use of dual-cham...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borne, Ryan T., Varosy, Paul, Lan, Zhou, Masoudi, Frederick A., Curtis, Jeptha P., Matlock, Daniel D., Peterson, Pamela N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941353/ https://www.ncbi.nlm.nih.gov/pubmed/35315917 http://dx.doi.org/10.1001/jamanetworkopen.2022.3429

Ejemplares similares

Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry
por: Borne, Ryan T., et al.
Publicado: (2021)

Implantable Cardioverter‐Defibrillators for Secondary Prevention of Sudden Cardiac Death: A Review
por: Borne, Ryan T., et al.
Publicado: (2017)

Single-chamber Versus Dual-chamber Implantable Cardioverter Defibrillators: Do We Need Physiologic Pacing in The Course?
por: Budeus, Marco, et al.
Publicado: (2006)

Comparison of Inappropriate Shocks and Other Health Outcomes Between Single‐ and Dual‐Chamber Implantable Cardioverter‐Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter‐Defibrillators
por: Peterson, Pamela N., et al.
Publicado: (2017)

Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter–defibrillators
por: Ross, Joseph S, et al.
Publicado: (2017)

A case of supraventricular tachycardia misdiagnosis after dual‐chamber implantable cardioverter defibrillator implantation with His bundle pacing
por: Sun, Xianchao, et al.
Publicado: (2023)

Low Body Mass Index but Not Obesity Is Associated With In-Hospital Adverse Events and Mortality Among Implantable Cardioverter-Defibrillator Recipients: Insights From the National Cardiovascular Data Registry
por: Hsu, Jonathan C., et al.
Publicado: (2012)

Complications and Mortality of Single Versus Dual Chamber Implantable Cardioverter Defibrillators
por: Bagherzadeh, Ataallah, et al.
Publicado: (2006)

Pause-prevention pacing in an extravascular implantable cardioverter-defibrillator
por: Sagi, Venkata, et al.
Publicado: (2023)

Outcomes of single- or dual-chamber implantable cardioverter defibrillator systems in Japanese patients
por: Ueda, Akiko, et al.
Publicado: (2016)

Dual‐chamber implantable cardioverter–defibrillator. Is it useful in patient with permanent atrial fibrillation?
por: Porres‐Aracama, José M., et al.
Publicado: (2016)

Atrial pacing–induced oversensing in subcutaneous implantable cardioverter-defibrillator
por: Wharmby, Amy, et al.
Publicado: (2023)

Arrhythmogenicity of anti-tachycardia pacing in patients with implantable cardioverter defibrillator
por: Awad, Sherien Samy, et al.
Publicado: (2023)

Recurrent shocks in a dual chamber implantable cardioverter defibrillator: Making sense of the chaos
por: Yeo, Colin, et al.
Publicado: (2018)

Analysis of Temporal Trends and Variation in the Use of Defibrillation Testing in Contemporary Practice
por: Borne, Ryan T., et al.
Publicado: (2019)

Antitachycardia pacing programming in implantable cardioverter defibrillator: A systematic review
por: De Maria, Elia, et al.
Publicado: (2017)

Survival Following Implantable Cardioverter‐Defibrillator Implantation in Patients With Amyloid Cardiomyopathy
por: Higgins, Angela Y., et al.
Publicado: (2020)

Epicardial vs. transvenous implantable cardioverter defibrillators in children
por: Le Bos, Pierre Antoine, et al.
Publicado: (2023)

Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter‐Defibrillators in the Cardiovascular Research Network
por: Greenlee, Robert T., et al.
Publicado: (2018)

Single‐ Versus Dual‐Chamber Implantable Cardioverter‐Defibrillator for Primary Prevention of Sudden Cardiac Death in the United States
por: Margolis, Gilad, et al.
Publicado: (2023)

Survival Probability and Survival Benefit Associated With Primary Prevention Implantable Cardioverter‐Defibrillator Generator Changes
por: Bilchick, Kenneth C., et al.
Publicado: (2022)

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention
por: Khazanie, Prateeti, et al.
Publicado: (2015)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Dual tachycardia induced by electrocution terminated by an implantable cardioverter-defibrillator
por: Kocovic, Nikola, et al.
Publicado: (2023)

Manual vs. automatic capture management in implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators
por: Murgatroyd, Francis D., et al.
Publicado: (2010)

Decision‐making regarding primary prevention implantable cardioverter‐defibrillators among older adults
por: Hess, Paul L., et al.
Publicado: (2019)

Managing cross talk between a subcutaneous implantable cardioverter-defibrillator and a dual-chamber unipolar pacemaker system
por: Kossidas, Konstantinos, et al.
Publicado: (2017)

Need for pacing in patients who qualify for an implantable cardioverter‐defibrillator: Clinical implications for the subcutaneous ICD
por: Kutyifa, Valentina, et al.
Publicado: (2020)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Relation between detection rate and inappropriate shocks in single versus dual chamber cardioverter-defibrillator – an analysis from the OPTION trial
por: Kolb, Christof, et al.
Publicado: (2016)

Clinical Course of Dual-Chamber Implantable Cardioverter-Defibrillator Recipients followed by Cardiac Remote Monitoring: Insights from the LION Registry
por: Schwab, Joerg O., et al.
Publicado: (2018)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

An inappropriate pacing threshold increase after repeated electrical storm in a patient with implantable cardioverter defibrillator
por: Zhu, Ye, et al.
Publicado: (2017)

Inhibition of pacing in a dependent patient with an implantable cardioverter-defibrillator and a left ventricular assist device
por: Murphy, Michele, et al.
Publicado: (2016)

A Case of 25 Inappropriate Automatic Implantable Cardioverter Defibrillator Shocks and 22 Episodes of Antitachycardia Pacing
por: Morrison, Nathan, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Extended charge banking model of dual path shocks for implantable cardioverter defibrillators
por: Dosdall, Derek J, et al.
Publicado: (2008)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_32sv9qo9umvrg6kjretktt81mm